NTLA Operating Margin
-711.66%TTM
Period ending:
NTLA FY Operating Margin%
170.46%-1590.97%
2014-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
NTLA operating margin history
Operating income as a percentage of revenue. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.
| Period ending | Operating Margin |
|---|---|
| -651.6676% | |
| -923.1007% | |
| -1,420.5127% | |
| -879.0392% | |
| -810.3652% | |
| -235.5123% | |
| -246.7763% | |
| -298.5805% | |
| -266.3208% | |
| -195.1514% | |
| -221.8564% | |
| 0% |
Compare operating margin
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) operating margin
- Bridgebio Pharma Inc (BBIO) operating margin
- Brightspring Health Services Inc (BTSG) operating margin
- Madrigal Pharmaceuticals Inc (MDGL) operating margin
- Ensign Group Inc (ENSG) operating margin
- Glaukos Corp (GKOS) operating margin
- Krystal Biotech Inc (KRYS) operating margin
- Twist Bioscience Corp (TWST) operating margin
Compare all covered stocks by operating margin →
All NTLA financial metrics · NTLA stock overview · How to interpret financial metrics
